ASCL1 and small cell lung carcinoma: Given the reported differences in cfDNA coverage at regions of transcription factor binding36, we evaluated whether fragment coverage and size across the observed 13,693 genome-wide binding sites of ASCL1 were altered in cfDNA of SCLC patients.